Masimo | Le Bénéfice D'Exploitation

Prix De L'Action
175.35
Variation Quotidienne
0.13 0.07%
Mensuellement
27.37%
Annuel
-7.11%
Q1 Prévisions
169.67




Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.25B 73M 2025-12
Accuray USD 4.71M 6.86M 2024-12
Align Technology USD 224.71M 40.06M 2025-12
AngioDynamics USD -9.97M 1.12M 2025-02
Artivion USD 4.39M 2.12M 2024-09
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
General Electric Aerospace USD 1.77B 536M 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
Masimo USD 83.6M 19.1M 2025-09
Medtronic USD 1.74B 40M 2025-12
Orthofix International USD -84.62M 65.72M 2024-12
Owens Minor USD 56.75M 56.63M 2025-06
ResMed USD 497.6M 35.25M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12


Masimo Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.